RESECTABLE CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Clinical trials for RESECTABLE CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK explained in plain language.

Never miss a new study

Get alerted when new RESECTABLE CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK trials appear

Sign up with your email to follow new studies for RESECTABLE CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug aims to shrink tumors before cancer surgery

Disease control Ongoing

This study is testing whether giving an immunotherapy drug called cemiplimab before surgery helps treat a type of skin cancer on the head and neck. The drug is designed to help the body's own immune system attack the cancer cells. Researchers want to see if the treatment shrinks …

Matched conditions: RESECTABLE CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

RESECTABLE CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Get alerted when new RESECTABLE CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK trials appear

New drug aims to shrink tumors before cancer surgery